Theratechnologies Inc. (TSE:TH - Get Free Report) shares crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$3.63 and traded as high as C$4.33. Theratechnologies shares last traded at C$4.31, with a volume of 32,757 shares changing hands.
Analyst Ratings Changes
Separately, Jones Trading downgraded Theratechnologies from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 3rd.
View Our Latest Research Report on Theratechnologies
Theratechnologies Price Performance
The firm has a 50-day simple moving average of C$3.67 and a two-hundred day simple moving average of C$3.01. The company has a market capitalization of C$137.51 million, a price-to-earnings ratio of -48.79, a P/E/G ratio of -8.50 and a beta of 1.73. The company has a current ratio of 1.08, a quick ratio of 0.64 and a debt-to-equity ratio of -293.92.
About Theratechnologies
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
See Also
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access